{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:46:40Z","timestamp":1785415600046,"version":"3.56.0"},"reference-count":69,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Marian University"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI199466"],"award-info":[{"award-number":["R21AI199466"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"award":["R21AI199466"],"award-info":[{"award-number":["R21AI199466"]}],"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>DNA viruses rely extensively on host cellular machinery, including replication factors and transcriptional systems, to persist after infection. These mechanisms make studying and targeting DNA viral proteins challenging, as they also play key roles in mammalian processes. Traditional strategies include CRISPR-mediated gene disruption and small interfering RNA (siRNA) to target host proteins. However, Proteolysis Targeting Chimeras (PROTACs) offer a novel strategy by enabling the selective and rapid degradation of specific viral or host proteins involved in the DNA viral lifecycle. PROTACs are heterobifunctional molecules composed of three key components: a ligand that binds the target protein, a chemical linker, and a ligand that recruits an E3 ubiquitin ligase. By simultaneously binding both the target protein and the E3 ligase, PROTACs form a ternary complex. This proximity enables the E3 ligase to ubiquitinate the target protein, marking it for recognition and subsequent degradation by the intracellular proteasome. This approach represents a promising avenue for targeting previously undruggable proteins and improving therapeutic outcomes in virus-associated malignancies. In this perspective, we describe studies that use PROTACs as tools to modulate host proteins to investigate DNA viral processes with temporal control of host protein expression, as well as the use of PROTACs as antivirals to directly target DNA viral proteins. We also provide a detailed chart summarizing known host-targeting PROTACs and their potential applications across different stages of DNA viral lifecycles, highlighting opportunities for future DNA virus research.<\/jats:p>","DOI":"10.3390\/v18060658","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:50:58Z","timestamp":1781157058000},"page":"658","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted Protein Degradation Strategies in DNA Virus Research"],"prefix":"10.3390","volume":"18","author":[{"given":"Michael","family":"Lam","sequence":"first","affiliation":[{"name":"Tom and Julie Wood College of Osteopathic Medicine, Marian University, Indianapolis, IN 46222, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayah","family":"Hill","sequence":"additional","affiliation":[{"name":"Tom and Julie Wood College of Osteopathic Medicine, Marian University, Indianapolis, IN 46222, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Thornburg","sequence":"additional","affiliation":[{"name":"Tom and Julie Wood College of Osteopathic Medicine, Marian University, Indianapolis, IN 46222, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha","family":"DeSmet","sequence":"additional","affiliation":[{"name":"Tom and Julie Wood College of Osteopathic Medicine, Marian University, Indianapolis, IN 46222, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-virology-092917-043534","article-title":"Virus DNA Replication and the Host DNA Damage Response","volume":"5","author":"Weitzman","year":"2018","journal-title":"Annu. Rev. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1099\/vir.0.044412-0","article-title":"DNA viruses and the cellular DNA-damage response","volume":"93","author":"Turnell","year":"2012","journal-title":"J. Gen. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.micro.112408.134016","article-title":"Genomes in conflict: Maintaining genome integrity during virus infection","volume":"64","author":"Weitzman","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","article-title":"Targeted protein degradation: Mechanisms, strategies and application","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/cbic.200400274","article-title":"Chemical approaches to controlling intracellular protein degradation","volume":"6","author":"Schneekloth","year":"2005","journal-title":"Chembiochem"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic in vivo protein knockdown by small-molecule PROTACs","volume":"11","author":"Bondeson","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.chembiol.2020.07.020","article-title":"PROTACs: An Emerging Therapeutic Modality in Precision Medicine","volume":"27","author":"Nalawansha","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","article-title":"Targeted protein degradation: Elements of PROTAC design","volume":"50","author":"Paiva","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41392-025-02392-8","article-title":"Targeting ubiquitination in disease and therapy","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Mancarella, C., Morrione, A., and Scotlandi, K. (2023). PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216346"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kanbar, K., El Darzi, R., and Jaalouk, D.E. (2024). Precision oncology revolution: CRISPR-Cas9 and PROTAC technologies unleashed. Front. Genet., 15.","DOI":"10.3389\/fgene.2024.1434002"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41392-024-02004-x","article-title":"Targeted protein degradation: Advances in drug discovery and clinical practice","volume":"9","author":"Zhong","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s00018-019-03112-6","article-title":"Advances in targeted degradation of endogenous proteins","volume":"76","author":"Fulcher","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105552","DOI":"10.1016\/j.antiviral.2023.105552","article-title":"Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription","volume":"211","author":"Yu","year":"2023","journal-title":"Antivir. Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hahn, F., Hamilton, S.T., Wangen, C., Wild, M., Kicuntod, J., Br\u00fcckner, N., Follett, J.E.L., Herrmann, L., Kheimar, A., and Kaufer, B.B. (2021). Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus Activity. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312858"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virusres.2016.12.006","article-title":"Involvement of Brd4 in different steps of the papillomavirus life cycle","volume":"231","author":"Iftner","year":"2017","journal-title":"Virus Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"McBride, A.A., Warburton, A., and Khurana, S. (2021). Multiple Roles of Brd4 in the Infectious Cycle of Human Papillomaviruses. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.725794"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e0129522","DOI":"10.1128\/jvi.01295-22","article-title":"SETD6 Regulates E2-Dependent Human Papillomavirus Transcription","volume":"96","author":"Jose","year":"2022","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Jose, L., Gonzalez, J., Kessinger, E., Androphy, E.J., and DeSmet, M. (2023). Focal Adhesion Kinase Binds to the HPV E2 Protein to Regulate Initial Replication after Infection. Pathogens, 12.","DOI":"10.3390\/pathogens12101203"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1016\/j.ymthe.2025.08.033","article-title":"Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer","volume":"33","author":"Smalley","year":"2025","journal-title":"Mol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e0126823","DOI":"10.1128\/jvi.01268-23","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation","volume":"98","author":"Nakajima","year":"2024","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e70765","DOI":"10.1002\/jmv.70765","article-title":"Targeted Protein Degradation of the Latency-Associated Nuclear Antigen Evicts Kaposi Sarcoma-Associated Herpesvirus Episomes from Infected Cells in Vitro","volume":"97","author":"McMahon","year":"2025","journal-title":"J. Med. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/acschembio.5b00442","article-title":"HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins","volume":"10","author":"Buckley","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"eaau5612","DOI":"10.1126\/scitranslmed.aau5612","article-title":"Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth","volume":"11","author":"Messick","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-026-02574-y","article-title":"Exogenous Epstein-Barr virus nuclear antigen 1 induces ADAR1-driven tumor resistance against immunotherapy","volume":"11","author":"Liu","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bbrc.2014.10.006","article-title":"Design of a PROTAC that antagonizes and destroys the cancer-forming X-protein of the hepatitis B virus","volume":"453","author":"Montrose","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.chom.2023.05.030","article-title":"Generation of host-directed and virus-specific antivirals using targeted protein degradation promoted by small molecules and viral RNA mimics","volume":"31","author":"Zhao","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nchembio.2538","article-title":"Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation","volume":"14","author":"Olson","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1158\/1078-0432.CCR-17-3119","article-title":"CDK9 Inhibitor FIT-039 Suppresses Viral Oncogenes E6 and E7 and Has a Therapeutic Effect on HPV-Induced Neoplasia","volume":"24","author":"Ajiro","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.antiviral.2016.08.008","article-title":"Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation","volume":"133","author":"Tanaka","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/1878-0261.13638","article-title":"Pharmacological degradation of ATR induces antiproliferative DNA replication stress in leukemic cells","volume":"18","author":"Kansy","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1021\/acs.jmedchem.4c00454","article-title":"Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing Colorectal Cancer Therapy via Synthetic Lethality with ATR Inhibitors","volume":"67","author":"Liu","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e0015323","DOI":"10.1128\/mmbr.00153-23","article-title":"How human papillomavirus (HPV) targets DNA repair pathways for viral replication: From guardian to accomplice","volume":"89","author":"Vats","year":"2025","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3390\/v7062752","article-title":"Activation of DNA Damage Response Pathways during Lytic Replication of KSHV","volume":"7","author":"Hollingworth","year":"2015","journal-title":"Viruses"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kumar, A., Sahu, S.K., Mohanty, S., Chakrabarti, S., Maji, S., Reddy, R.R., Jha, A.K., Goswami, C., Kundu, C.N., and Rajasubramaniam, S. (2014). Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2\/M cell cycle blocks by modulating ATM\/ATR mediated checkpoint pathway. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100228"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Hau, P.M., and Tsao, S.W. (2017). Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle. Viruses, 9.","DOI":"10.3390\/v9110341"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00795-009-0457-8","article-title":"Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis","volume":"42","author":"Matsuda","year":"2009","journal-title":"Med. Mol. Morphol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kleinberger, T. (2020). En Guard! The Interactions between Adenoviruses and the DNA Damage Response. Viruses, 12.","DOI":"10.3390\/v12090996"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cels.2024.03.003","article-title":"DNA-PK and ATM drive phosphorylation signatures that antagonistically regulate cytokine responses to herpesvirus infection or DNA damage","volume":"15","author":"Justice","year":"2024","journal-title":"Cell Syst."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"20196","DOI":"10.1021\/acsomega.3c01558","article-title":"Synthetic and Medicinal Chemistry Approaches Toward WEE1 Kinase Inhibitors and Its Degraders","volume":"8","author":"Alli","year":"2023","journal-title":"ACS Omega"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Byskata, K., Lukoseviciute, M., Tuti, F., Zupancic, M., Kostopoulou, O.N., Holzhauser, S., and Dalianis, T. (2022). Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited. Cancers, 15.","DOI":"10.3390\/cancers15010093"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1038\/s41388-024-03119-9","article-title":"EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth","volume":"43","author":"Corbin","year":"2024","journal-title":"Oncogene"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e114462","DOI":"10.15252\/embj.2023114462","article-title":"EZH2 inhibition stimulates repetitive element expression and viral mimicry in resting splenic B cells","volume":"42","author":"Kim","year":"2023","journal-title":"EMBO J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"10-1128","DOI":"10.1128\/mSphere.00478-18","article-title":"Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells","volume":"3","author":"Ichikawa","year":"2018","journal-title":"mSphere"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1038\/s41467-022-34562-5","article-title":"Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers","volume":"13","author":"Cantley","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1038\/s41467-025-64669-4","article-title":"Rational design of potent small-molecule SMARCA2\/A4 degraders acting via the recruitment of FBXO22","volume":"16","author":"Villemure","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1007\/s11427-025-3154-3","article-title":"The SWI\/SNF complex mediated chromatin remodeling promotes hepatitis B virus cccDNA transcription","volume":"68","author":"Yuan","year":"2025","journal-title":"Sci. China Life Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4161\/cc.11.3.19115","article-title":"Brg1 regulates the transcription of human papillomavirus type 18 E6 and E7 genes","volume":"11","author":"He","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000318871","article-title":"hSNF5 is required for human papillomavirus E2-driven transcriptional activation and DNA replication","volume":"54","author":"Cha","year":"2011","journal-title":"Intervirology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"116612","DOI":"10.1016\/j.ejmech.2024.116612","article-title":"Design, synthesis and antitumor activity of a novel FGFR2-selective degrader to overcome resistance of the FGFR2(V564F) gatekeeper mutation based on a pan-FGFR inhibitor","volume":"275","author":"Hu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"108109","DOI":"10.1016\/j.bioorg.2024.108109","article-title":"Design, synthesis, and biological evaluation of novel FGFR1 PROTACs","volume":"155","author":"Wang","year":"2025","journal-title":"Bioorg. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"128982","DOI":"10.1016\/j.bmcl.2022.128982","article-title":"Development of selective FGFR1 degraders using a Rapid synthesis of proteolysis targeting Chimera (Rapid-TAC) platform","volume":"75","author":"Guo","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.virol.2018.05.013","article-title":"Papillomavirus E2 protein is regulated by specific fibroblast growth factor receptors","volume":"521","author":"DeSmet","year":"2018","journal-title":"Virology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wang, X., Li, J., Schowalter, R.M., Jiao, J., Buck, C.B., and You, J. (2012). Bromodomain protein Brd4 plays a key role in Merkel cell polyomavirus DNA replication. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003021"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Palermo, R.D., Webb, H.M., and West, M.J. (2011). RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002334"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"12009","DOI":"10.1128\/JVI.01680-08","article-title":"The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4","volume":"82","author":"Lin","year":"2008","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e00040-17","DOI":"10.1128\/MCB.00040-17","article-title":"Transcriptional Elongation Control of Hepatitis B Virus Covalently Closed Circular DNA Transcription by Super Elongation Complex and BRD4","volume":"37","author":"Francisco","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"8909","DOI":"10.1128\/JVI.00502-06","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes","volume":"80","author":"You","year":"2006","journal-title":"J. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Hainley, L.E., Hughson, M.S., Narendran, A., Smith, R., Arthur, J., Hayner-Buchan, A., Conti, D.J., Lehman, J.M., and Friedrich, T.D. (2021). Chk1 and the Host Cell DNA Damage Response as a Potential Antiviral Target in BK Polyomavirus Infection. Viruses, 13.","DOI":"10.3390\/v13071353"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1172\/JCI43976","article-title":"Genomic DNA damage and ATR-Chk1 signaling determine oncolytic adenoviral efficacy in human ovarian cancer cells","volume":"121","author":"Connell","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e0088924","DOI":"10.1128\/jvi.00889-24","article-title":"Inactivation of checkpoint kinase 1 (Chk1) during parvovirus minute virus of mice (MVM) infection inhibits cellular homologous recombination repair and facilitates viral genome replication","volume":"98","author":"Etingov","year":"2024","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"117062","DOI":"10.1016\/j.ejmech.2024.117062","article-title":"Discovery of a potent PARP1 PROTAC as a chemosensitizer for the treatment of colorectal cancer","volume":"282","author":"Wu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/biom2040524","article-title":"Functional Aspects of PARP1 in DNA Repair and Transcription","volume":"2","author":"Ko","year":"2012","journal-title":"Biomolecules"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Chung, W.C., and Song, M.J. (2021). Virus-Host Interplay Between Poly (ADP-Ribose) Polymerase 1 and Oncogenic Gammaherpesviruses. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.811671"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41467-025-56317-8","article-title":"Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV","volume":"16","author":"Newton","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2014.10.004","article-title":"Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production","volume":"148","author":"Phillips","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/6\/658\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:28:53Z","timestamp":1781324933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/6\/658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":69,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["v18060658"],"URL":"https:\/\/doi.org\/10.3390\/v18060658","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]}}}